Intraperitoneal (IP) Vancomycin Therapy for CAPI) Peritonitis—A Prospective, Randomized Comparison of Intermittent v Continuous Therapy

American Journal of Kidney Diseases

Volumn 12, Issue 4, 1988, Pages 304-306

  Boyce, Neil W ^a   Wood, Colin ^a   Thomson, Napier M ^a   Kerr, Peter ^a   Atkins, Robert C ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

peritoneal dialysis; peritonitis; Vancomycin

Indexed keywords

VANCOMYCIN;

CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PERITONEAL DIALYSIS; PERITONITIS;

EID: 0023700858     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(88)80224-5     Document Type: Article

References (11)

1. Mortality and morbidity in continuous ambulatory peritoneal dialysis
2. CAPD related peritonitis management and antibiotic therapy recommendations: Travenol peritonitis management advisory committee
3. Management of peritonitis complicating CAPD peritonitis
4. Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients
5. Vancomycin pharmokinetics in CAPD patients with peritonitis
6. Efficiency of intravenous vancomycin in the treatment of gram-positive peritonitis in long-term peritoneal dialysis
7. Diagnosis, prevention and treatment of peritonitis
8. A randomized, multicentre clinical trial to evaluate the effects of an ultraviolet germicidal system on peritonitis rate in CAPD
9. Pharmacokinetics and efficacy of intraperitoneal vancomycin given as a single dose
10. Simplified antibiotic regimen for treatment of peritonitis in continuous ambulatory peritoneal dialysis
11. Chemical peritonitis due to intraperitoneal vancomycin